Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis (HEMO)
Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease
Sponsor: Brigham and Women's Hospital
A NA clinical study on End Stage Renal Disease, this trial is completed. The trial is conducted by Brigham and Women's Hospital and has accumulated 8 data snapshots since 1995. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Feb 2020 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2019 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE2 → NA
-
Jan 2017 — Oct 2017 [monthly]
Completed PHASE2
First recorded
Mar 1995
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Duke University
- Emory University
- Icahn School of Medicine at Mount Sinai
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Main Line Health
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- The Cleveland Clinic
- Tufts Medical Center
- University of Alabama at Birmingham
- University of California, Davis
- University of Illinois at Chicago
- University of Rochester
- University of Texas Southwestern Medical Center
- University of Utah
- Vanderbilt University
- Wake Forest University Health Sciences
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .